Recent molecular genetic studies and methodological issues in suicide research.

Area of Science:

• Genetics
• Psychiatry
• Molecular Biology

Background:

• Suicide behavior (SB) encompasses a range of actions from suicidal ideation to completed suicide.
• Genetic factors, including heritability and twin studies, strongly suggest a genetic susceptibility to SB.
• Environmental factors interact with multiple genes, classifying SB as a complex genetic phenotype.

Purpose of the Study:

• To review recent molecular genetic studies on suicide behavior (SB).
• To explore the role of epigenetics and pharmacogenetics in SB.
• To identify new avenues for SB genetic research and clinical translation.

Main Methods:

• Review of case-control association studies.
• Analysis of genome gene-expression microarray data.
• Examination of genome-wide association (GWA) studies.
• Inclusion of epigenetics and pharmacogenetics research.

Main Results:

• Case-control association studies are the primary method, identifying potential genes like serotonin transporter and BDNF, though findings are not always consistent.
• Emerging genome-wide studies (gene expression and GWA) offer broader insights, unconstrained by prior knowledge of pathophysiology.
• Challenges include the unclear clinical translation of GWA findings and inconsistent SB phenotype definitions across studies.

Conclusions:

• SB is a complex trait involving multiple genes and environmental interactions.
• Whole genome approaches combined with case-control studies can enhance understanding of SB genetics.
• Improved genetic insights may lead to better screening, prevention, and management of SB.